In summary, our results suggest that exosomal miR-197-3p can regulate the AKT/mTOR pathway, affecting the progression of NPC, and can target HSPA5 to inhibit autophagy and improve the radiotherapy sensitivity of NPC (Figure 9). This evidence concerns the gene MTOR and nasopharyngeal carcinoma.